Celsis Acquires In Vitro Technologies, Expanding Services for ADME Studies

September 27, 2006
BioPharm International Editors

Celsis International plc (Chicago, IL, www.celsis.com) has acquired In Vitro Technologies, Inc. (Baltimore, MD, www.invitrotech.com).

Celsis International plc (Chicago, IL, www.celsis.com) has acquired In Vitro Technologies, Inc. (Baltimore, MD, www.invitrotech.com). The acquisition adds a suite of products and services for use in in vitro ADME toxicology studies.

Related Content:

News | Mergers and Acquisitions